Krystal Biotech, Inc. (KRYS)
NASDAQ·Healthcare·Biotechnology
$298.25
-0.86%
Mkt Cap $8.92B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (17 analysts)
$395.20
Range $300.00 – $474.00
Implied Upside
+32.5%
Consensus $395.20 vs current $298.25
NASDAQ·Healthcare·Biotechnology
$298.25
-0.86%
Mkt Cap $8.92B
Buy
12
Hold
0
Sell
0
Price Target (17 analysts)
$395.20
Range $300.00 – $474.00
+32.5%
Consensus $395.20 vs current $298.25